Skip to content
healthcare.dev

Onpattro

NDC 71336-1000, patisiran, injection, lipid complex, from Alnylam Pharmaceuticals, Inc..

Product NDC
71336-1000
Status
Listed
Labeler
Alnylam Pharmaceuticals, Inc.
Dosage form
INJECTION, LIPID COMPLEX
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210922
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1000 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PATISIRAN SODIUM2 mg/mL

Pharmacologic classes

Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]; Transthyretin-directed RNA Interaction [EPC]

Package NDCNDC-11Package
71336-1000-1713361000011 VIAL, SINGLE-DOSE in 1 CARTON (71336-1000-1) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e87ec36f-b4b4-49d4-aea4-d4ffb09b0970
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71336-1000

Use it

Look up 71336-1000 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1000 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71336-1000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.